Search research articles
Contact Us
Filters
Showing results (161-170 of 175) with videos related to
Page
of 18
Sort By:
RSC Medicinal Chemistry
|
January 7, 2026
Synthesis and evaluation of enantiomeric quinoline-2-carboxamides: positron emission tomography imaging agents for the translocator protein
Lachlan J N Waddell, Mark G MacAskill, Holly McErlain, et al.
Medical and Pediatric Oncology
|
December 1, 1996
Comparison of idarubicin to daunomycin in a randomized multidrug treatment of childhood acute lymphoblastic leukemia at first bone marrow relapse: a report from the Children's Cancer Group
S A Feig, M M Ames, H N Sather, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 1998
6-Aminonicotinamide sensitizes human tumor cell lines to cisplatin
I I Budihardjo, D L Walker, P A Svingen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2000
Phase I and pharmacokinetic study of irinotecan and docetaxel in patients with advanced solid tumors: preliminary evidence of clinical activity
A A Adjei, C E Klein, H Kastrissios, et al.
Biochemical Pharmacology
|
October 6, 1999
Murine pharmacokinetics of 6-aminonicotinamide (NSC 21206), a novel biochemical modulating agent
D L Walker, J M Reid, P A Svingen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 1, 1999
Phase I trial of dolastatin-10 (NSC 376128) in patients with advanced solid tumors
H C Pitot, E A McElroy, J M Reid, et al.
Journal of Neuro-Oncology
|
February 24, 2001
A randomized phase II and pharmacokinetic study of dacarbazine in patients with recurrent glioma
S V Rajkumar, J M Reid, P J Novotny, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 29, 2000
Phase I dose-finding and pharmacokinetic trial of irinotecan hydrochloride (CPT-11) using a once-every-three-week dosing schedule for patients with advanced solid tumor malignancy
H C Pitot, R M Goldberg, J M Reid, et al.
European Journal of Neurology
|
June 12, 2012
Neurosarcoidosis-related intracranial haemorrhage: three new cases and a systematic review of the literature
J P O'Dwyer, B A Al-Moyeed, M A Farrell, et al.
EJNMMI Physics
|
December 8, 2025
Performance evaluation of the nanoScan<sup>®</sup> P123S total-body PET
Dániel Réti, Carlos-Alcaide Corral, Islay Cranston, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 175) with videos related to
Sort By:
Page
of 18
RSC Medicinal Chemistry
|
January 7, 2026
Synthesis and evaluation of enantiomeric quinoline-2-carboxamides: positron emission tomography imaging agents for the translocator protein
Lachlan J N Waddell, Mark G MacAskill, Holly McErlain, et al.
Medical and Pediatric Oncology
|
December 1, 1996
Comparison of idarubicin to daunomycin in a randomized multidrug treatment of childhood acute lymphoblastic leukemia at first bone marrow relapse: a report from the Children's Cancer Group
S A Feig, M M Ames, H N Sather, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 1998
6-Aminonicotinamide sensitizes human tumor cell lines to cisplatin
I I Budihardjo, D L Walker, P A Svingen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2000
Phase I and pharmacokinetic study of irinotecan and docetaxel in patients with advanced solid tumors: preliminary evidence of clinical activity
A A Adjei, C E Klein, H Kastrissios, et al.
Biochemical Pharmacology
|
October 6, 1999
Murine pharmacokinetics of 6-aminonicotinamide (NSC 21206), a novel biochemical modulating agent
D L Walker, J M Reid, P A Svingen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 1, 1999
Phase I trial of dolastatin-10 (NSC 376128) in patients with advanced solid tumors
H C Pitot, E A McElroy, J M Reid, et al.
Journal of Neuro-Oncology
|
February 24, 2001
A randomized phase II and pharmacokinetic study of dacarbazine in patients with recurrent glioma
S V Rajkumar, J M Reid, P J Novotny, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 29, 2000
Phase I dose-finding and pharmacokinetic trial of irinotecan hydrochloride (CPT-11) using a once-every-three-week dosing schedule for patients with advanced solid tumor malignancy
H C Pitot, R M Goldberg, J M Reid, et al.
European Journal of Neurology
|
June 12, 2012
Neurosarcoidosis-related intracranial haemorrhage: three new cases and a systematic review of the literature
J P O'Dwyer, B A Al-Moyeed, M A Farrell, et al.
EJNMMI Physics
|
December 8, 2025
Performance evaluation of the nanoScan<sup>®</sup> P123S total-body PET
Dániel Réti, Carlos-Alcaide Corral, Islay Cranston, et al.
Page
of 18